Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 18 articles:
HTML format
Text format



Single Articles


    July 2018
  1. WEBSTER P
    Hepatitis C treatment in Guatemala: the struggle for access.
    Lancet. 2018;392:269-270.
    PubMed     Text format    


  2. THE LANCET
    Transforming treatment for hepatitis C.
    Lancet. 2018;392:254.
    PubMed     Text format    


    June 2018
  3. WEBSTER P
    Hepatitis C-infected organ transplants offer hope.
    Lancet. 2018;391:2485.
    PubMed     Text format    


    March 2018
  4. MOIN A, Fatima H, Qadir TF
    Tackling hepatitis C-Pakistan's road to success.
    Lancet. 2018;391:834-835.
    PubMed     Text format    


  5. WANDELER G, Coffie PA, Kuniholm MH, Ocama P, et al
    Issues with measuring hepatitis prevalence in resource-limited settings.
    Lancet. 2018;391:835-836.
    PubMed     Text format    


    November 2017
  6. GARTNER C, Miller A, Bonevski B
    Extending survival for people with hepatitis C using tobacco dependence treatment.
    Lancet. 2017;390:2033.
    PubMed     Text format    


    September 2017
  7. GARCIA-TARDON N, Gresnigt TM, Fofanah AB, Grobusch MP, et al
    Hepatitis B and C in Tonkolili Province, Sierra Leone.
    Lancet. 2017;390:1485.
    PubMed     Text format    


    July 2017
  8. WIKTOR SZ, Scott JD
    What is the impact of treatment for hepatitis C virus infection?
    Lancet. 2017;390:107-109.
    PubMed     Text format    


  9. DOYLE JS, Thompson AJ, Higgs P, Stoove M, et al
    New hepatitis C antiviral treatments eliminate the virus.
    Lancet. 2017 Jul 6. pii: S0140-6736(17)31817.
    PubMed     Text format    


    February 2017
  10. EKSER B, Mangus RS
    Spontaneous bacterial peritonitis.
    Lancet. 2017;389:735.
    PubMed     Text format    


    January 2017
  11. VAN DER REE MH, de Vree JM, Stelma F, Willemse S, et al
    Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.
    Lancet. 2017 Jan 10. pii: S0140-6736(16)31715.
    PubMed     Text format     Abstract available


  12. ZEISEL MB, Baumert TF
    Clinical development of hepatitis C virus host-targeting agents.
    Lancet. 2017 Jan 10. pii: S0140-6736(17)30043.
    PubMed     Text format    


    December 2016
  13. LIVINEC B
    Estimating the burden of hepatitis.
    Lancet. 2016;388:2738-2739.
    PubMed     Text format    


    November 2016
  14. GHINEA N, Lipworth W, Day R, Hill A, et al
    Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries.
    Lancet. 2016 Nov 3. pii: S0140-6736(16)32051.
    PubMed     Text format    


    September 2016
  15. MOHAMMADI D
    Lasker Foundation announces award winners for 2016.
    Lancet. 2016;388:1144-5.
    PubMed     Text format    


  16. PIROTH L, Rabaud C, Rey D, Schmit JL, et al
    Hepatitis C: the path towards effective universal therapy.
    Lancet. 2016;388:1051-2.
    PubMed     Text format    


    July 2016
  17. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available


  18. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: